Loading...
XPAR
CVX
Market cap141mUSD
Mar 02, Last price  
3.20EUR
Name

Affluent Medical SAS

Chart & performance

D1W1MN
XPAR:CVX chart
P/E
—
P/S
30.54
EPS
—
Div yield, %
—
Shrs. gr., 5y
16.18%
Rev. gr., 5y
23.58%
Revenues
4m
+236.44%
3,00043,0001,429,000824,0001,451,0001,339,0001,224,0004,118,000
Net income
-15m
L-5.84%
-5,837,000-8,752,000-16,589,000-14,319,000-14,820,000-15,227,000-15,653,000-14,739,000
CFO
-11m
L-6.06%
0-10,842,000-12,187,000-8,936,000-12,364,000-11,081,000-12,054,000-11,324,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Affluent Medical S.A., a French enterprise, specializes in the creation of minimally invasive medical solutions designed to address cardiovascular and vascular conditions. Its product pipeline includes the Kardiozis technology, engineered to manage abdominal aortic aneurysms, alongside the Kalios and Epygon implants, which target mitral insufficiency. Additionally, the company offers the Artus implant, an advanced electromechanical artificial sphincter devised for the comprehensive treatment of severe urinary incontinence in both female and male patients. Established in 2011, its headquarters are situated in Aix-en-Provence, France.

Key people

Michel Therin
Chairman of the Board · since 2023
Sebastien Ladet
Chief Executive Officer · since 2024
Christophe de Vregille
Chief Financial Officer · since 2023
Celine Buard
Marketing Director · since 2022
Claire Andre
Director of Quality Assurance
Olivier Bellamy
Director of Industrialization · since 2022
Eric Jague
Director of Regulatory Affairs
Francois Laborde
Chief Surgical Officer · since 2023
Marion Melot
Artus Program Director · since 2022
Laurent Miranda
Kalios Programme Director · since 2022
Benjamin Renault
Chief Development Officer · since 2023
Director, Representative of Truffle Capital · since 2018
Dominique Carouge
Independent Director · since 2020
Patrick Coulombier
Independent Director · since 2023
Soad El Ghazouani Achik
Independent Director · since 2021
Ellen Roche
Independent Director · since 2021
Liane Teplitsky
Independent Director · since 2025
IPO date
Jun 14, 2021
Employees
59
Domiciled in
FR
Incorporated in
FR
Headquarters & legal address
900 RUE ANDRE AMPERE
BATIMENTS A ET C
AIX-EN-PROVENCE 13290
FR
Previous name
AFFLUENT MEDICAL

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT